September 17, 2007 — Novatrix Biomedical Inc. announced that it has formed a new company, Curexo Medical Inc. (CMI), with the acquisition of all assets of Integrated Surgical Systems Inc. (ISS).
Under the licensing agreement, Curexo Inc., will transfer all the assets acquired from ISS to CMI.
Curexo Medical Inc., located in Sacramento, California, retained the former officers and employees of ISS in order to facilitate rapid introduction of its surgical robotics system into the U.S. orthopedic market.
The system is called ROBODOC Surgical Assistant System (the ROBODOC). The ROBODOC has been very well received by hospitals and orthopedic surgeons from both academic institutions and private hospitals in Europe and Asia, including Japan, Korea and India. The system has already been approved by Korea's regulatory agency, KFDA.
Novatrix Biomedical Inc., based in Southern California, develops proprietary technologies in the drug delivery field.
Curexo Medical, Inc. also announced that it has submitted a 510(k) pre-market notification to the U.S. FDA for the clearance of its ROBODOC Surgical Assistance System for marketing in the U.S. A 90-day period is customary for FDA review of a 510(k) submission.
For more information: www.robodoc.com